Cells for Cells S.A. is a Chilean-based biotech company dedicated to the research, development and commercialization of cell therapies and tissue-engineered revolutionary solutions. The company counts with a broad portfolio of more than 10 technologies including Cellistem®OA, a clinical trial-supported cell therapy for the treatment of knee osteoarthritis, Inkure®, a bioink for the treatment of focal chondral lesions, Oxium®Exo, a culture media for the production of exosomes, and Veintis™, a bioinspired tissue-engineered vascular graft for vascular bypass applications, among others. Cells for Cells S.A. (a.k.a. C4C) is a spin off from Universidad de los Andes, Chile, and was founded in 2010.
Company Details
- Employees
- 29
- Founded
- -
- Address
- Avenida Isidora Goyenechea 2939, Piso 11,chile
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- c4c.cl
- Keywords
- Regenerative Medicine, Biotechnology, Cell Therapy, Tissue Engineering, Bioengineering, Biomaterials, Exosomes, Orthobiologics.
- HQ
- Las Condes, Región Metropolitana de Santiago
Cells For Cells Questions
Cells For Cells's website is c4c.cl
Cells For Cells's LinkedIn profile is https://cl.linkedin.com/company/cells-for-cells
Cells For Cells has
29 employees.
View email and phone details for 29
employees at Cells For Cells.
Cells For Cells's industry is
Biotechnology Research
Cells For Cells's top competitors are
Botanical Solution,
Impact Center Of Interventional Medicine For Precision And Advanced Cellular Therapy,
Phagelab,
Fundación Ciencia & Vida,
Redbionova,
Taag Genetics,
Protera,
Biotecom Chile,
Grupobios,
Kura Biotech.
Cells For Cells's categories are Biotechnology Research
Cells For Cells's founding year is 2010
